HomeInsightsResults

Kwality Pharmaceuticals Ltd Quarterly Result

Kwality Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

8.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Net Profit

₹ 8.46

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 90.26 crore as compare to the Jun '24 revenue of ₹ 80.36 crore. This represent the growth of 12.319564%.
  • The ebitda of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 19.88 crore as compare to the Jun '24 ebitda of ₹ 17.62 crore. This represent the growth of 12.8263235%.
  • The net profit of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 8.46 crore as compare to the Jun '24 net profit of ₹ 8.35 crore. This represent the growth of 1.3173611%.

Results Analysis

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024862.7
21 Nov 2024872.45
19 Nov 2024870.8
18 Nov 2024907.25
14 Nov 2024890.05
13 Nov 2024885.65
12 Nov 2024868.75
11 Nov 2024878.65
08 Nov 2024924.85
07 Nov 2024941.05

Historical Revenue of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals to hold board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30...

Read more

23 Oct 202410:21

News

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

10 Sep 202410:31

News

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

10 Sep 202410:28

News

Kwality Pharmaceuticals to discuss results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10...

Read more

06 Aug 202416:30

News

Kwality Pharmaceuticals to table results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23...

Read more

09 May 202410:49

News

Kwality Pharmaceuticals to declare Quarterly Result

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

27 Jan 202416:03

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Kwality Pharmaceuticals Ltd Quarterly Result

What is the EPS of Kwality Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Kwality Pharmaceuticals Ltd is 32.99. An EPS is the amount of net income attributed to each share of a common stock.

How is Kwality Pharmaceuticals Ltd EPS calculated?

The EPS of Kwality Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kwality Pharmaceuticals Ltd report its EPS?

Kwality Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kwality Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Kwality Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kwality Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Kwality Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*